AcouSort’s chairman, Martin Olin, has been appointed CEO of the Norwegian biotechnology company BerGenBio. Olin, who retains his role at AcouSort, will take up his new position on September 8. BerGenBio is a clinical-stage biopharmaceutical company developing selective AXL inhibitors He replaces Richard Godfrey who has held the position of CEO at BerGenBio for 12 year….
©2023 All rights reserved LaingBuisson 
